iCell Gene Therapeutics Announces Upcoming Conference Presentations
STONY BROOK, N.Y., Oct. 05, 2026 (GLOBE NEWSWIRE) -- iCell Gene Therapeutics ("iCell Gene"), a clinical-stage biopharmaceutical company developing autologous and in vivo CAR T cell therapies for autoimmune diseases and cancer, today announced that Jennifer Chow, CEO will present and meet with investors and potential pa…
Short extract only — this publisher licenses its text. Read the full release at the source.
Cancel anytime · CA$99/month


